Eastwood Bio-Medical Canada (TSXV:EBM) LT-Debt-to-Total-Asset : 0.00 (As of Jan. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Eastwood Bio-Medical Canada LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Eastwood Bio-Medical Canada's long-term debt to total assests ratio for the quarter that ended in Jan. 2025 was 0.00.

Eastwood Bio-Medical Canada's long-term debt to total assets ratio stayed the same from Jan. 2024 (0.00) to Jan. 2025 (0.00).

Eastwood Bio-Medical Canada LT-Debt-to-Total-Asset Historical Data

The historical data trend for Eastwood Bio-Medical Canada's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eastwood Bio-Medical Canada LT-Debt-to-Total-Asset Chart

Eastwood Bio-Medical Canada Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.03

0.05

0.06

Eastwood Bio-Medical Canada Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Eastwood Bio-Medical Canada LT-Debt-to-Total-Asset Calculation

Eastwood Bio-Medical Canada's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Oct. 2024 is calculated as

LT Debt to Total Assets (A: Oct. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Oct. 2024 )	/	Total Assets (A: Oct. 2024 )
	=	0	/	0.274
	=	0.00

Eastwood Bio-Medical Canada's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2025 is calculated as

LT Debt to Total Assets (Q: Jan. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jan. 2025 )	/	Total Assets (Q: Jan. 2025 )
	=	0	/	0.204
	=	0.00

Eastwood Bio-Medical Canada (TSXV:EBM) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Eastwood Bio-Medical Canada LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Eastwood Bio-Medical Canada's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Eastwood Bio-Medical Canada Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » Eastwood Bio-Medical Canada Inc (TSXV:EBM) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

4871 Shell Road, Suite 1130, Richmond, BC, CAN, V6X 3Z6

Website

https://www.eleotin.ca

Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in U.S., Canada and Asia. The company generates maximum revenue from Asia.

Executives

Yunji Kim	Senior Officer
Youngsoo Kim	Director or Senior Officer of 10% Security Holder

Eastwood Bio-Medical Canada Headlines

No Headlines